Physician profile
Kacey Call
NPI 1427896836
$1,638.93
in general payments reported to CMS, 2019-2025
16 companies · $1,600 in 2025
The $1,600 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $38.51 · 2025: $1,600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,639.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,638.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $448.74 | 2025 | |
| Viiv Healthcare Company | $216.67 | 2025 | Rukobia, Dovato, Apretude |
| Abbvie INC. | $175.86 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $144.63 | 2025 | Airsupra, Farxiga |
| Novo Nordisk INC | $135.73 | 2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $128.30 | 2024-2025 | Mounjaro, Zepbound, Kisunla |
| Exact Sciences Corporation | $88.03 | 2025 | Cologuard Collection Kit |
| Theratechnologies INC. | $59.08 | 2025 | Trogarzo, Egrifta |
| Pfizer INC. | $58.86 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $47.58 | 2025 | Trintellix |
| Amgen INC. | $28.89 | 2025 | Otezla, Repatha |
| Glaxosmithkline, LLC. | $28.41 | 2025 | Trelegy Ellipta |
| Azurity Pharmaceuticals, INC. | $23.24 | 2025 | Azmiro |
| Antares Pharma, INC. | $20.11 | 2025 | Xyosted |
| Napo Pharmaceuticals INC | $19.05 | 2025 | Mytesi |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $15.75 | 2024 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kacey Call listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.